(COAT) trial those participants who started ART 1-2 weeks after cryptococcal diagnosis had a 73% higher mortality rate compared with those started 5-6 weeks after diagnosis. Immune reconstitution inflammatory syndrome (IRIS) is reported in 20% of patients with cryptococcal meningitis starting ART; management of this condition will be discussed.
Among all patients with CD4 counts < 100 presenting for HIV care in sub-Saharan Africa 2-20% are found to have cryptococcal antigenaemia even though most do not have clinical features of meningitis at the time. Observational data and findings of a clusterrandomised trial suggest that pre-emptive fluconazole for such antigenaemic patients may prevent meningitis and death. The optimal dose and duration of fluconazole for this indication needs to be defined.
Other important opportunistic disease contributing to HIVrelated mortality in the region (pneumocystis pneumonia, Karposi's sarcoma and chronic gastro-enteritis) will be discussed, but this presentation will not address HIV-associated tuberculosis. 
Challenges in the management of opportunistic infections: Focus on Southeast Asia

A. Kamarulzaman
University of Malaya, Kuala Lumpur, Malaysia
Abstract: Late presenters into HIV care remain common in South East Asia. In an analysis of more than 3700 patients in an Asian observational cohort, more than 72% were late presenters ie presenting into HIV care for the first time with CD4 of < 200 cells/mm 3 or with an AIDS defining illness. Consequently physicians in South East Asia continue to manage patients who present with a myriad of opportunistic infections including toxoplasmosis, CMV infection, disseminated fungal infections and tuberculosis. Advanced HIV infection also leads to an increased risk for immune reconstitution syndrome which may present as a diagnostic and or therapeutic challenge in these patients.
Apart from late presentation, substance use disorder and coinfections with hepatitis B and C are also relatively common in the region and can lead to additional challenges in the management of opportunistic infections and provision of antiretroviral therapy. Drug-drug interaction and hepatotoxicity are amongst the difficulties that may be encountered in these patients.
A further important consideration when managing patients with opportunistic infections is the optimal timing for the initiation of antiretroviral therapy. In recent years several large clinical trials have been performed to address this issue especially in relation to tuberculosis. These and data from observational studies would suggest that early initiation of antiretroviral therapy in the setting of active opportunistic infections confer survival benefits with the exception of tuberculous meningitis and cryptococcal meningitis.
Despite the advances that have been made in antiretroviral therapy and a global call for early and immediate initiation of treatment on diagnosis, a large majority of patients continue to present with late stage disease with opportunistic infections. Physicians in South East Asia and other low and middle income countries need to continue be equipped with the ability to diagnose and manage these infections effectively. Abstract: Some opportunistic diseases are either exclusive or more commonly observed in South American AIDS patients than in those from different parts of the world. Interactions between HIV and endemic parasitic and other locally prevalent pathogens occur frequently in South America. However, knowledge about the impact of these interactions has been accumulating only recently.
HIV infection may alter the natural history of tropical diseases in different ways. Diagnosis and treatment may be altered and an increased pathogen burden may augment morbidity and mortality. The impact that tropical diseases have on the course of HIV infection may also be deleterious. Many intercurrent infections increase the HIV viral load enhancing the progression of HIV disease and the risk of transmission of HIV to non-infected individuals. Similarly, chronic immunomodulation by pathogens, such as helminths and protozoa, may considerably accelerate the natural history of HIV infection.
Characteristics of coinfection in the region with HIV and some emblematic endemic pathologies, such as paracoccidioidomycosis, histoplasmosis, Chagas' disease, visceral leishmaniasis, strongyloidiasis and HTLV1, as well as some unique challenges posed by them, are reviewed in detail. 
Mers-CoV: From camels to humans
Z. Memish
Ministry of Health, Riyadh, Saudi Arabia
Abstract: The Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel enzootic beta coronavirus that was first described in September 2012. The clinical spectrum of MERS-CoV infection in humans ranges from an asymptomatic or mild respiratory illness to severe pneumonia and multi-organ failure; overall mortality is around 37.5%. Bats harbor several beta coronaviruses that are closely related to MERS-CoV but more research is needed to establish the relationship between bats and MERS-CoV. The seroprevalence of MERS-CoV antibodies is very high in dromedary camels in Eastern Africa and the Arabian Peninsula. MERS-CoV RNA and viable virus have been isolated from dromedary camels, including some with respiratory symptoms. Furthermore, near-identical strains of MERS-CoV have been isolated from epidemiologically linked humans and camels, confirming intertransmission, most probably from camels to humans. Though inter-human spread within health care settings is responsible for the majority of reported MERS-CoV cases, the virus is incapable at present of causing sustained human-to-human transmission. Clusters can be readily controlled with implementation of appropriate infection control procedures. Phylogenetic and sequencing data strongly suggest that MERS-CoV originated from bat ancestors after undergoing a recombination event in the Spike protein, possibly in dromedary camels in Africa, before its exportation to the Arabian Peninsula along the camel trading routes. Amongst the important measures to control MERS-CoV spread are strict regulation of camel movement, regular herd screening and isolation of infected camels, use of personal protective equipment by camel handlers and enforcing rules banning all consumption of unpasteurized camel milk and urine. 
Climate change and other drivers of infectious diseases -Focus on Asia and the Pacific
D. Harley
College of Medicine, Acton, Australia
Abstract: Infectious disease epidemiology is determined by characteristics of host, agent, and environment. Climate is one important environmental influence on the incidence and distribution of infectious diseases. But climate interacts with host characteristics at individual and population levels, pathogen biology, and other facets of the biotic and abiotic environment.
This presentation will consider mechanisms via which climate influences infectious diseases and present empirical evidence for some associations. The interaction of climate with other environmental, as well as host and agent characteristics will then be discussed. Examples from Asia and the Pacific, including dengue and tuberculosis, will be used. The future for infectious diseases under climate change will be considered. 
